PharmaCyte Biotech, Inc.
PMCB
$1.64
-$0.12-6.82%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/4/2025
-
Ticker Report
9/28/2024
-
Ticker Report
9/28/2024
-
Zolmax
9/13/2024
-
Zolmax
9/13/2024
-
Ticker Report
8/17/2024
-
Ticker Report
5/21/2024
-
Seeking Alpha - Healthcare
5/21/2024
-
The Fly
5/21/2024
-
Business Wire
3/27/2024
-
Zolmax
3/22/2024
-
Simply Wall St
3/19/2024
-
InvestorPlace
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, December 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
917-595-2850
Address
3960 Howard Hughes Parkway
Las Vegas, NV 89169
Las Vegas, NV 89169
Country
Year Founded
Business Description
Sector
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a...
more
